Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice

Journal of Interferon and Cytokine Research

Volumn 33, Issue 5, 2013, Pages 254-260

  Braun, Olga ^a   Dewitz, Christin ^a   Möller Hackbarth, Katja ^a   Scheller, Jürgen ^b   Schiffelholz, Thomas ^a   Baier, Paul Christian ^a   Rose John, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; MALE; MEMORY; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BLOOD CIRCULATION; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; INTERLEUKIN-6; MALE; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PAIN THRESHOLD; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; TRANSGENES;

EID: 84877860166     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0096     Document Type: Article

References (50)

1. Andratsch M, Mair N, Constantin CE, Scherbakov N, Benetti C, Quarta S, Vogl C, Sailer CA, Uceyler N, Brockhaus J, Martini R, Sommer C, Zeilhofer HU, Muller W, Kuner R, Davis JB, Rose-John S, Kress M. 2009. A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci 29:13473-13483.
2. Armario A, Hernandez J, Bluethmann H, Hidalgo J. 1998. IL-6 deficiency leads to increased emotionality in mice: Evidence in transgenic mice carrying a null mutation for IL-6. J Neuroimmunol 92:160-169.
3. Baier PC, May U, Scheller J, Rose-John S, Schiffelholz T. 2009. Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. Behav Brain Res 200:192-196.
4. Ballard FJ, Hanson RW. 1967. Phosphoenolpyruvate carboxykinase and pyruvate carboxylase in developing rat liver. Biochem J 104:866-871.
5. Balschun D, Wetzel W, Del Rey A, Pitossi F, Schneider H, Zuschratter W, Besedovsky HO. 2004. Interleukin-6: A cytokine to forget. FASEB J 18:1788-1790.
6. Bellinger FP, Madamba SG, Campbell IL, Siggins GR. 1995. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett 198:95-98.
7. Benedict C, Scheller J, Rose-John S, Born J, Marshall L. 2009. Enhancing influence of intranasal interleukin-6 on slow-wave activity and memory consolidation during sleep. FASEB J 23:3629-3636.
8. Bluthe RM, Michaud B, Poli V, Dantzer R. 2000. Role of IL-6 in cytokine-induced sickness behavior: A study with IL-6 deficient mice. Physiol Behav 70:367-373.
9. Boettger MK, Leuchtweis J, Kummel D, Gajda M, Brauer R, Schaible HG. 2010. Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther 12:R140.
10. ButterweckV, Prinz S, SchwaningerM. 2003. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice. Behav Brain Res 144:49-56.
11. Diamant M, Rieneck K, Mechti N, Zhang XG, Svenson M, Bendtzen K, Klein B. 1997. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130. FEBS Lett 412:379-384.
12. Dimitrov S, Lange T, Benedict C, Nowell MA, Jones SA, Scheller J, Rose-John S, Born J. 2006. Sleep enhances IL-6 trans-signaling in humans. FASEB J 20:2174-2176.
13. Ennaceur A, Neave N, Aggleton JP. 1997. Spontaneous object recognition and object location memory in rats: The effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 113: 509-519.
14. Gadient RA, Otten U. 1994. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 182:243-246.
15. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. 1997. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 94:1500-1505.
16. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149-1157.
17. Hogan D, Morrow JD, Smith EM, Opp MR. 2003. Interleukin-6 alters sleep of rats. J Neuroimmunol 137:59-66.
18. Hryniewicz A, Bialuk I, Kaminski KA, Winnicka MM. 2007. Impairment of recognition memory in interleukin-6 knock-out mice. Eur J Pharmacol 577:219-220.
19. Islam O, Gong X, Rose-John S, Heese K. 2009. Interleukin-6 and neural stem cells: More than gliogenesis. Mol Biol Cell 20: 188-199.
20. Jones SA, Scheller J, Rose-John S. 2011. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121:3375-3383.
21. Jostock T, Mullberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S. 2001. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268: 160-167.
22. Lemmers A, Gustot T, Durnez A, Evrard S, Moreno C, Quertinmont E, Vercruysse V, Demetter P, Franchimont D, Le Moine O, Geerts A, Deviere J. 2009. An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol 156:518-527.
23. Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y. 1997. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 748:30-38.
24. Linker RA, Luhder F, Kallen KJ, Lee DH, Engelhardt B, Rose-John S, Gold R. 2008. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. J Neuroimmunol 205:64-72.
25. Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, Mohs R, Pasinetti GM. 2000. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57:1153-1160.
26. Maione D, Di Carlo E, Li W, Musiani P, Modesti A, Peters M, Rose-John S, Della Rocca C, Tripodi M, Lazzaro D, Taub R, Savino R, Ciliberto G. 1998. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 17:5588-5597.
27. Manjavachi MN, Motta EM, Marotta DM, Leite DF, Calixto JB. 2010. Mechanisms involved in IL-6-induced muscular mechanical hyperalgesia in mice. Pain 151:345-355.
28. Marsland AL, Petersen KL, Sathanoori R, Muldoon MF, Neumann SA, Ryan C, Flory JD, Manuck SB. 2006. Interleukin-6 covaries inversely with cognitive performance among middleaged community volunteers. Psychosom Med 68:895-903.
29. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S. 1998. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A 95:3251-3256.
30. Marz P, Heese K, Hock C, Golombowski S, Muller-Spahn F, Rose-John S, Otten U. 1997. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neuroscience Lett 239:29-32.
31. Marz P, Otten U, Rose-John S. 1999. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur J Neurosci 11:2995-3004.
32. Matarese G, La Cava A. 2004. The intricate interface between immune system and metabolism. Trends Immunol 25: 193-200.
33. May U, Schiffelholz T, Baier PC, Krueger JM, Rose-John S, Scheller J. 2009. IL-6-trans-signalling increases rapid-eyemovement sleep in rats. Eur J Pharmacol 613:141-145.
34. Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
35. Murphy PG, Ramer MS, Borthwick L, Gauldie J, Richardson PM, Bisby MA. 1999. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 11:2243-2253.
36. Obreja O, Biasio W, Andratsch M, Lips KS, Rathee PK, Ludwig A, Rose-John S, Kress M. 2005. Fast modulation of heatactivated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain 128:1634-1641.
37. Obreja O, Schmelz M, Poole S, Kress M. 2002. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 96:57-62.
38. Peters M, Schirmacher P, Goldschmitt J, Odenthal M, Peschel C, Fattori E, Ciliberto G, Dienes HP, Meyer zum Buschenfelde KH, Rose-John S. 1997. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med 185:755-766.
39. Rabe B, Chalaris A, May U, Waetzig GH, Seegert D, Williams AS, Jones SA, Rose-John S, Scheller J. 2008. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 111:1021-1028.
40. Samuelsson AM, Jennische E, Hansson HA, Holmang A. 2006. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 290:R1345-1356.
41. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. 2011. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878-888.
42. Schobitz B, de Kloet ER, Sutanto W, Holsboer F. 1993. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 5:1426-1435.
43. Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, Johnson RW. 2006. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci 26:10709-10716.
44. Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, Tosato G, Janz S, Scheller J, Rose-John S. 2012. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood 119:5173-5181.
45. Swiergiel AH, Dunn AJ. 2006. Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav Brain Res 171:94-108.
46. Tanaka M, Kishimura M, Ozaki S, Osakada F, Hashimoto H, Okubo M, Murakami M, Nakao K. 2000. Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis. J Clin Invest 106:137-144.
47. Tanaka T, Narazaki M, Kishimoto T. 2012. Therapeutic targeting of the interleukin-6 receptor. Annu Rev Pharmacol Toxicol 52:199-219.
48. Tancredi V, D'Antuono M, Cafe C, Giovedi S, Bue MC, D'Arcangelo G, Onofri F, Benfenati F. 2000. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J Neurochem 75:634-643.
49. Weschenfelder J, Sander C, Kluge M, Kirkby KC, Himmerich H. 2012. The influence of cytokines on wakefulness regulation: Clinical relevance, mechanisms and methodological problems. Psychiatr Danub 24:112-126.
50. Wolsk E, Mygind H, Grondahl TS, Pedersen BK, van Hall G. 2010. IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab 299:E832- E840.